10 March 2021
Visiongain has published a new report on Aesthetic Lasers Market Report to 2031: Forecasts By Product (Standalone Laser Devices (Carbon Dioxide (CO2) Lasers, Erbium YAG Lasers, Diode Lasers, Pulsed Dye Lasers (PDL), Nd: Yag Lasers, Alexandrite Lasers, and Other Devices (Ruby, Argon, Krypton, and Erbium: glass Lasers) and Multiplatform Laser Devices), By Application (Vascular Lesions, Acne, & Scars, Pigmented Lesions & Tattoos, Hair Removal, Skin Rejuvenation, Leg Veins & Varicose Veins, and Other Applications (Onychomycosis, Gynecological Conditions)), By End User (Hospitals, Private Clinics, and Medical Spas)PLUS COVID-19 Recovery Scenarios.
Global Aesthetic/Cosmetic Lasers market size is projected to reach US$ XX Million in 2021 and is expected to display strong revenue growth through to 2031.
COVID-19 Impact on Aesthetic/Cosmetic Lasers Market
The COVID-19 pandemic has deleteriously affected all the countries and industries. Similarly, the Aesthetic/Cosmetic Lasers market is anticipated to take a hit. The target industry is now facing challenges to manage the interrupted demand and supply of components. Also, unpredictable and disturbing supply chain activities and the unavailability of human resources are anticipated to impact the target industry growth. Hence, the overall COVID-19 impact is expected to continue to moderate for the global key players operating in the industry.
Growing Acceptance of Energy-based Cosmetic/Aesthetic Devices
The growing significance of physical looks is the key factor persuading people to shift towards minimally invasive aesthetic treatments, such as skin tightening, facial wrinkles, acne scars, hair removal, and other skin blemishes, etc. In turn, it is likely to rise the need for cosmetic/aesthetic lasers therefore fueling the target industry growth.
The launch of the high-tech-driven procedure and advanced aesthetic laser systems is gaining traction among the woman predominantly to undergo aesthetic treatments, such as hair removal, acne reduction, etc. The growing demand for laser treatments is impelling global key players to launch robust and novel energy-based aesthetic laser devices in the market and eventually boosting the cosmetics/aesthetic lasers market in the given time frame.
For instance, in April 2019, Lumenis Ltd. introduced its Legend Pro+ platform, an exclusive multi-use platform with complementary technologies. On 29th July 2019, U.S. Food and Drug Administration (FDA) approved Cynosure’s two products TempSure® and SculpSure®. These products will aid the company to grow its product portfolio of innovative aesthetic treatments.
Growing Obese Population and Incidence of Skin Conditions to Fuel the Target Industry Growth
The growing obesity among people owing to inactive lifestyles in developed and developing nations is persuading people to undergo body reformation treatments. The minimally invasive and rapid action of lasers is grasping the patient’s considerations to undergo numerous cosmetic procedures. This is one of the major reasons that are projected to boost the demand for cosmetics/aesthetic lasers. According to the CDC, in the U.S., nearly 93.3 million (estimated 38.9%) people suffered from obesity in 2015-2016.
The increasing occurrence of skin diseases such as rosacea has led to the use of aesthetic/cosmetic lasers for treatment. In turn, it is expected to demand minimally invasive energy-based aesthetic lasers devices. According to the British Journal of Dermatology, states that people with rosacea were around 5.46% in the overall population and around 2.39% among dermatology patients worldwide.
The Growing Potential of Developing Economies
Developing nations such as China, India offer lucrative opportunities for the global key players operating in the target industry. The countries have immense growth potential due to growing disposable income, changing lifestyles, and rising concern regarding appearance. In India, the target industry is recording speedy growth, mostly across the megacities of the country. The growing acceptance of innovative technologies among the population is further pushing the Indian Aesthetic/cosmetic Laser market. The additional highly influential factors such as the high competition, arrival of new business, and funding from the local players and the foreign players looking for a large population base.
Major players in the global Aesthetic/Cosmetic Lasers market include Aerolase, Cutera, Inc., El.En. SpA, Sciton, Inc., Cynosure, Inc., SharpLight Technologies, Lumenis Ltd., Syneron Medical Inc., Alma Lasers, Ltd., and Solta Medical.
The key players have adopted new product development, product launches, product approval, agreement, partnerships, and merger as its key business development strategies to tap into the global Aesthetic/Cosmetic Lasers market. For instance, on 17th August 2020, Lumenis Ltd. introduced its newest invention, the NuEra Tight with FocalRF technology. The platform is custom-made for non-invasive RF body treatments and distinctive to every patient.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
29 July 2021
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.